Sex, Age, BMI, and C-Reactive Protein Impact the Odds of Developing Hypertension-Findings Based on Data From the Health and Retirement Study (HRS).

American Journal of Hypertension
Hollie SpeerAndrew J McKune

Abstract

Hypertension is a major contributor to cardiovascular diseases and premature death, therefore determining factors that contribute to such a high burden of disease is critically important. This study examined anthropometric and physical measurements, as well as blood and saliva biomarkers, as predictors for hypertension using datasets from the 2008 Health and Retirement Study. A total of 2,924 participants (aged 74.84 ± 6.45 years) were included. Binary logistic regression was performed to ascertain the effects of sex, age, telomere length, C-reactive protein (CRP), body mass index (BMI), and additional markers on the odds of developing hypertension. Males had 2.3 times the odds (odds ratio (OR) = 2.313, confidence interval (CI) 95% (1.391, 3.845); P = 0.001) of being hypertensive if they were obese, females had 1.7 times the odds (OR = 1.788, CI 95% (1.260, 2.536); P = 0.001) if overweight, and 2.4 times (OR = 2.479, CI 95% (1.693, 3.630); P < 0.001) if obese. Age in females was an independent predictor where every 1-year increase in age was tied to a 5.1% increase in being hypertensive (OR = 1.051, CI 95% (1.027, 1.075); P <0.001), and CRP (>3 mg/l) had 1.4 times the odds (OR = 1.447, CI 95% (1.079, 1.942); P = 0.014). This st...Continue Reading

References

Nov 1, 1995·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·W J Evans
Sep 26, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M T GuagnanoS Sensi
Aug 15, 2002·Cardiovascular Research·Kwang Kon Koh
Jul 24, 2003·Journal of the American College of Cardiology·Yukihito HigashiMasao Yoshizumi
Dec 11, 2003·JAMA : the Journal of the American Medical Association·Howard D SessoPaul M Ridker
May 8, 2004·Experimental Gerontology·Karen Suárez KrabbeHelle Bruunsgaard
Jun 12, 2004·Current Opinion in Clinical Nutrition and Metabolic Care·Elena VolpiSatoshi Fujita
Apr 12, 2005·Cardiovascular Research·María Dolores Edo, Vicente Andrés
Jun 28, 2005·Cancer Letters·Devanand Sarkar, Paul B Fisher
Aug 2, 2005·Journal of the American College of Cardiology·Amit KheraJames A de Lemos
Nov 30, 2007·Journal of Human Hypertension·F-W LungW-T Kao
Jul 2, 2009·The Journal of Clinical Endocrinology and Metabolism·Amit KheraJames A de Lemos
Oct 30, 2010·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Karen Anne MatherHelen Christensen
Sep 14, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yukihito HigashiKensuke Noma
Nov 15, 2013·Journal of Human Hypertension·F G Hage
May 27, 2014·Calcified Tissue International·Daniel BaylisCyrus Cooper
Nov 29, 2014·Rejuvenation Research·Nuria GaratacheaAlejandro Lucia
Nov 13, 2015·The Gerontologist·Eileen M Crimmins
Dec 31, 2015·Current Opinion in Nephrology and Hypertension·Sergey I Dikalov, Anna E Dikalova
Feb 3, 2016·Ageing Research Reviews·Thomas W Buford
Jul 27, 2018·Nature Reviews. Endocrinology·Claudio FranceschiAurelia Santoro
Oct 22, 2019·Clinical Interventions in Aging·Richard W Bohannon
Oct 31, 2019·The Journal of International Medical Research·Pan LiuLina Ma
Aug 30, 2020·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Daniela MedinaAmy C Arnold
Sep 22, 2020·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Chloe E TaylorCyndya A Shibao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.